 | Up a level |
Jump to: 2014
Number of items: 1.
2014
Burmester, G., Rubbert-Roth, A., Cantagrel, A., Hall, S., Leszczynski, P., Feldman, D., Rangaraj, M., Roane, G., Ludivico, C., Mysler, E., Nash, P., Wells, C., Bennett, M. and Vranic, I (2014). THE EFFICACY AND SAFETY OF TOCILIZUMAB SUBCUTANEOUS VERSUS TOCILIZUMAB INTRAVENOUS, IN COMBINATION WITH TRADITIONAL DMARDS IN PATIENTS WITH RA AT 49 WEEKS (SUMMACTA) (ENCORE). Intern. Med. J., 44. S. 25 - 27. HOBOKEN: WILEY-BLACKWELL. ISSN 1445-5994